PYXS vs XRAY · rev $2.8M vs rev $1.78B
Pyxis Oncology Inc (PYXS) versus Dentsply Sirona Inc (XRAY) — a side-by-side from cached financials, not a winner call.
Pyxis Oncology Inc (PYXS) is a biotechnology company listed on NASDAQ.
Dentsply Sirona Inc (XRAY) is a medical instruments & supplies company listed on NASDAQ.
Latest reported PYXS revenue for 2025-09-30 was $2.8M. Net income was -$22.0M. Revenue was up 0.0% from 2025-06-30 to 2025-09-30. PYXS currently screens at market cap $109.6M.
Latest reported XRAY revenue for 2026-06-30 was $1.78B. Net income was $27.0M. XRAY currently screens at market cap $2.01B.
PYXS currently screens at market cap $109.6M. XRAY currently screens at market cap $2.01B.
Not investment advice. Open the PYXS and XRAY stock pages for the full models.
Not investment advice.